Baudax Bio Inc BXRXQ

Healthcare

Baudax Bio, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products for hospital and related acute care settings. The Company's lead product candidate is ANJESO injection. ANJESO is a cyclooxygenase-2 (COX-2), a preferential, non-steroidal anti-inflammatory for the management of moderate to severe pain, which could be administered alone or in combination with other non-NSAID analgesics. Its pipeline of other pharmaceutical products includes two neuromuscular blocking agents (NMBs) and a chemical reversal agent, which are used as muscle paralyzing agents to facilitate intubation and surgery. Its product pipeline includes NMBAs, which are used as muscle paralyzing agents to facilitate intubation and surgery. It is developing intermediate-acting NMBA, BX-1000, an ultrashort-acting NMBA, BX-2000, and a reversal agent specific to its NMBAs. It is also focused on the discovery and development of Treg-based cell therapies for autoimmune diseases.

PINL:BXRXQ - Post by User

Baudax Bio Inc

<< Previous

Bullboard Posts

Next >>

Post by 9Isluckyon May 11, 2020 1:54pm

157 Views

Post# 31012974

Who is managing bxrx?

Is the mgmt. the same for Reph and Bxrx?If so,it doesn't bode well after Reph reported earnings so bad that the stock is down 40%.Also since the units on the offering sold for $3.25,any time the stock gets near that price,lt offers the unit holders an opportunity to sell the stock and have zero invested,while having all the upside with the warrants.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects